0001127602-23-008787.txt : 20230303
0001127602-23-008787.hdr.sgml : 20230303
20230303170459
ACCESSION NUMBER: 0001127602-23-008787
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Munsch Frederick
CENTRAL INDEX KEY: 0001864367
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41380
FILM NUMBER: 23705501
MAIL ADDRESS:
STREET 1: C/O BLCO
STREET 2: 400 SOMERSET CORPORATE BLVD.
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch & Lomb Corp
CENTRAL INDEX KEY: 0001860742
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 APPLEWOOD CRESCENT
CITY: VAUGHAN
STATE: A6
ZIP: L4K 4B4
BUSINESS PHONE: 908-541-5456
MAIL ADDRESS:
STREET 1: 520 APPLEWOOD CRESCENT
CITY: VAUGHAN
STATE: A6
ZIP: L4K 4B4
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-03-01
0001860742
Bausch & Lomb Corp
BLCO
0001864367
Munsch Frederick
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT
VAUGHAN
A6
L4K 4B4
ONTARIO, CANADA
1
SVP, Controller and CAO
Common Shares, No Par Value
2023-03-01
4
A
0
7529
0
A
41251
D
Non-Qualified Stock Options (right to purchase)
17.96
2023-03-01
4
A
0
24103
0
A
Common Shares, No Par Value
24103
24103
D
Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation.
Reflects the grant of stock options to purchase Common Shares under the Plan.
The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement.
The stock options will expire on the tenth anniversary of the grant date.
/s/ Debra E. Levin, attorney-in-fact
2023-03-03